To validate the diagnostic value of five hub genes (TRIM22, IFI6, IFITM1, IFI35, and IRF9) in PM/DM patients, the next phase of our study was to execute ROC analyses to investigate the sensitivity and specificity of hub genes for PM/DM diagnosis. The gene discussed is TRIM22; the disease is dermatomyositis.